Coronary stents seeded with human trophoblastic endovascular progenitor cells show accelerated strut coverage without excessive neointimal proliferation in a porcine model

EuroIntervention

Volumn 10, Issue 6, 2014, Pages 709-716

  Raina, Tushar ^a   Iqbal, Javaid ^a   Arnold, Nadine ^a   Moore, Harry ^a   Aflatoonian, Behrouz ^a   Walsh, Jim ^b   Whitehouse, Sam ^c   Al Lamee, Kadem ^c   Francis, Sheila ^a   Gunn, Julian ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Intercytex Ltd   (United Kingdom)

^c Lombard Medical Technologies PLC   (United Kingdom)

Author keywords

Endothelial progenitor cells; Endothelialisation; Neointimal hyperplasia; Percutaneous coronary intervention; Restenosis

Indexed keywords

INDIUM 111;

ANGIOCARDIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CELL FATE; CELL REGENERATION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY STENT; DEVICE SAFETY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTRAVASCULAR ULTRASOUND; ISOTOPE LABELING; MALE; MORPHOMETRICS; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; SCANNING ELECTRON MICROSCOPY; SWINE; TREATMENT RESPONSE; TROPHOBLAST; TROPHOBLASTIC ENDOVASCULAR PROGENITOR CELL; TROPHOBLASTIC ENDOVASCULAR PROGENITOR CELL SEEDED CORONARY STENT; ANIMAL; CELL CULTURE; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CYTOLOGY; INTERVENTIONAL ULTRASONOGRAPHY; NEOINTIMA; PATHOLOGY; PHYSIOLOGY; PIG; STEM CELL; STENT; TISSUE REGENERATION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ANGIOGRAPHY; EMBRYONIC STEM CELLS; ENDOTHELIUM, VASCULAR; GUIDED TISSUE REGENERATION; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; NEOINTIMA; STEM CELLS; STENTS; SWINE; TROPHOBLASTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84908281804     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I6A123     Document Type: Article

References (30)

1. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J. 2010;31:2501-55.
2. Iqbal J, Serruys PW, Taggart DP. Optimal revascularization for complex coronary artery disease. Nat Rev Cardiol. 2013;10: 635-47.
3. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, Meier B, Goy JJ, Vogt P, Kappenberger L, et al. Angiographic follow-up after placement of a selfexpanding coronary-artery stent. N Engl J Med. 1991;324:13-7.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
5. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.
6. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-78.
7. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356: 1009-19.
8. Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 2013;9:62-9.
9. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293:2126-30.
10. Burzotta F, Parma A, Pristipino C, Manzoli A, Belloni F, Sardella G, Rigattieri S, Danesi A, Mazzarotto P, Summaria F, Romagnoli E, Prati F, Trani C, Crea F. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study. Eur Heart J. 2008;29:3011-21.
11. Iqbal J, Gunn J, Serruys PW. Coronary stents: historical development, current status and future directions. Br Med Bull. 2013;106:193-211.
12. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-5.
13. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
14. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ. Endothelial progenitor cell capture by stents coated with antibody against CD34: the healing-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry. J Am Coll Cardiol. 2005;45:1574-9.
15. Low AF, Lee CH, Teo SG, Chan MY, Tay E, Lee YP, Chong E, Co M, Tin Hay E, Lim YT, Tan HC. Effectiveness and safety of the genous endothelial progenitor cellcapture stent in acute ST-elevation myocardial infarction. Am J Cardiol. 2011;108:202-5.
16. Beijk MA, Klomp M, Verouden NJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Scheunhage E, Piek JJ, Tijssen JG, de Winter RJ. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J. 2010;31:1055-64.
17. Klomp M, Beijk MA, Varma C, Koolen JJ, Teiger E, Richardt G, Bea F, van Geloven N, Verouden NJ, Chan YK, Woudstra P, Damman P, Tijssen JG, de Winter RJ. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc Interv. 2011;4:896-904.
18. Garg S, Duckers HJ, Serruys PW. Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice? Eur Heart J. 2010;31:1032-5.
19. Harun R, Ruban L, Matin M, Draper J, Jenkins NM, Liew GC, Andrews PW, Li TC, Laird SM, Moore HD. Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events. Hum Reprod. 2006;21:1349-58.
20. Udayashankar R, Baker D, Tuckerman E, Laird S, Li TC, Moore HD. Characterization of invasive trophoblasts generated from human embryonic stem cells. Hum Reprod. 2011;26: 398-406.
21. Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P, Moore H. Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev Biol Anim. 2010;46:236-41.
22. Malik N, Gunn J, Holt CM, Shepherd L, Francis SE, Newman CM, Crossman DC, Cumberland DC. Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry, and transmission electron microscopy. Heart. 1998;80:509-16.
23. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-74.
24. Swanson N, Hogrefe K, Javed Q, Malik N, Gershlick AH. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia. J Invasive Cardiol. 2003;15:688-92.
25. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-7.
26. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348:593-600.
27. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-8.
28. Banerjee S, Brilakis E, Zhang S, Roesle M, Lindsey J, Philips B, Blewett CG, Terada LS. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis. 2006;189:70-5.
29. Arts CH, De Groot PG, Attevelt N, Heijnen-Snyder GJ, Verhagen HJ, Eikelboom BC, Blankensteijn JD. In vivo transluminal microvascular endothelial cell seeding on balloon injured rabbit arteries. J Cardiovasc Surg (Torino). 2004;45:129-37.
30. Wu X, Wang G, Tang C, Zhang D, Li Z, Du D, Zhang Z. Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent. J Biomed Mater Res A. 2011;98:442-9.